Xcout Intel
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. is a startup holding company operating in the therapeutics and drug pipeline sector in Washington, United States.
Subscribe to see Bonum Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Bonum Therapeutics, Inc. at a glance
Bonum Therapeutics, Inc. is a biopharma company headquartered in United States. Its most recent funding round raised $26.9M in April 2026. Xcout tracks 20 named people at Bonum Therapeutics, Inc., including John Mulligan (Chief Executive Officer).
Bonum Therapeutics, Inc. leadership
- John MulliganChief Executive Officer
- Diane HollenbaughChief Scientific Officer
- Neela PatelChief Business Officer
- Karl HandelsmanFounder & Managing Partner, Codon Capital
- Cindy YeeVice President, Corporate Strategy & Operations
- Justin Killebrew, PhDVice President of Biology
14 more named people on record for Bonum Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Bonum Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $26.9M | — | |
| SEC Form D filing | $45M | — | |
| Series A | $93M | — | |
| SEC Form D filing | $1.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Bonum Therapeutics, Inc. competitors
A few of Bonum Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Bridge Medicines LLC is a drug discovery holding company headquartered in New York, NY, that accelerates the path of therapeutic pipelines from research to patients.
Renibus Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Southlake, Texas, dedicated to transforming outcomes in specialty therapeutics and disease treatments.
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Good Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington. The firm focuses on drug discovery and the development of novel therapeutic pipelines and biopharmaceuticals.
Get Bonum Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Bonum Therapeutics, Inc. in Xcout Intel
- 20 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access